Serum Institute resumes COVID-19 vaccine exports
PTI, Nov 26, 2021, 6:29 PM IST
Serum Institute of India — the world’s largest vaccine maker — on Friday said it has resumed exports of Covishield vaccine to low- and middle-income countries with the first batch of consignment leaving its Pune facility.
The vaccine maker has cumulatively produced 1.25 billion doses so far, a company statement said.
”The first batches of its COVISHIELD COVID-19 vaccine left the SII manufacturing facility in Pune earlier today, for distribution to low- and middle-income countries via the COVAX mechanism,” it said. ”SII’s supply of doses via COVAX is expected to increase substantially into Quarter 1 2022,” it added.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
CM Vijayan opens Huddle Global; Says Kerala will be key player in India’s deep tech ambitions
Over 1,80,000 cases disposed off by exclusive POCSO courts: WCD
Blast near PVR in Delhi’s Prashant Vihar, 1 injured
ECI must clarify how voter turnout rose by over 7 per cent after polling ended: Patole
Indian culture resonates globally: PM Modi
MUST WATCH
Latest Additions
CM Vijayan opens Huddle Global; Says Kerala will be key player in India’s deep tech ambitions
Bengaluru to host Aero India 2025 from Feb 10-14
Karnataka cabinet decides to reopen graft case against Ex-CM Yediyurappa and family
Man attacks nurse inside hospital, caught on camera
Special tribute concert for legendary singer SPB to be held in Bengaluru on Dec 8
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.